Meeting
2015 Breast Cancer Symposium
Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer.
Authors
Nimmi S. Kapoor
Breastlink Medical Group, Orange, CA
Nimmi S. Kapoor , Lisa D. Curcio , Carlee A. Blakemore , Amy K. Bremner , Rachel E. McFarland , John G. West , Kimberly C. Banks
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Risk Assessment, Prevention, Early Detection, Screening, and Local/Regional Therapy
Track
Local/Regional Therapy,Systemic Therapy,Risk Assessment, Prevention, Early Detection, and Screening
Sub Track
Genomics
Citation
J Clin Oncol 33, 2015 (suppl 28S; abstr 16)
DOI
10.1200/jco.2015.33.28_suppl.16
Abstract #
16
Poster Bd #
D8
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Impact of pre-surgical germline multigene panel testing on choice of surgery for breast cancer.
First Author: Elena Zarcaro
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian
Poster
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
First Author: Nicole Casasanta
Poster
2023 ASCO Annual Meeting
Comprehensive profiling of mutational signatures and machine learning and subtypes of homologous recombination deficiency.
First Author: Joonoh Lim